All Cancer Microbiology articles – Page 4
-
NewsRight versus left: Colorectal cancer’s two microbial worlds
New research reveals that the mucosal microbiome varies dramatically depending on whether a tumor arises on the right or left side of the colorectum, suggesting that the microbial environment surrounding tumors may be as geographically distinct as the tumors themselves.
-
NewsLarge-scale microbiome study identifies robust colorectal cancer signature
Researchers have identified a robust microbial signature associated with colorectal cancer. The study also analysed 906 intestinal tissue samples to compare stool-based microbiome signals with microbes found directly in tumour tissue.
-
NewsAlgae microbots take aim at bladder cancer
Tiny algae-based robots guided by magnets could improve bladder cancer treatment by boosting delivery of chemotherapy drugs into tumours. Tracked using real-time imaging, the miniature robots help drugs penetrate deep into tumour tissue while limiting damage to healthy cells.
-
NewsNew study shows near-complete reduction of cervical cancer deaths among HPV-vaccinated adolescents in England
A new study suggests the Human Papilloma Virus (HPV) vaccine may be responsible for a near-complete protective effect against death from cervical cancer among women under 30 in England who received the vaccine between 12-18 years old.
-
NewsTherapeutic vaccine shows mixed efficacy in preventing head and neck cancer recurrence
Researchers explore the effectivity of new therapeutic cancer vaccine in preventing the recurence of human papillomavirus triggered cancers.
-
NewsPlants could be used to grow medicines in space, study shows
Astronauts on long space missions may one day use plants to produce fresh stocks of medicines on demand. Researchers developed a simple method to grow and repeatedly harvest plant virus-based pharmaceuticals from plants under space-like conditions, without destroying the plants or generating large amounts of waste.
-
NewsResearchers combine bacteria and viruses to demonstrate a new way to fight cancer
Researchers have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors. Animal models treated with this combination of bacteria and viruses saw almost all their tumors eliminated and lived significantly longer.
-
NewsResearcher studying probiotics to fight acid reflux and esophageal cancer
Patients with acid reflux, which occurs when stomach acid pushes up into the esophagus, know the symptoms all too well: heartburn, belching, chest pain and trouble swallowing. Acid reflux also increases the risk of esophageal cancer, but researchers are investigating how a simple probiotic could treat and prevent both conditions.
-
NewsStudy identifies serious infection risks linked to targeted cancer therapies
A major real-world study has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies. Some ADCs were associated with substantial rates of severe neutropenia – dangerously low levels of infection-fighting white blood cells – and related complications.
-
CareersA week in the life of a Parvovirus researcher
Alejandro Fernández Llorente works as a predoctoral researcher at Centro de Biología Molecular Severo Ochoa (CBM-CSIC), a prestigious biomedical research centre located in Madrid, Spain.
-
NewsColorectal cancer risk linked to gut microbiome alterations
A study finds that more than a decade after removal of an adenoma from the colon, the gut microbiome still partly resembles that observed in colorectal cancer (CRC).
-
NewsNew study links gut bacteria to immunotherapy success in melanoma patients
Researchers have identified specific gut bacteria linked to better responses to cancer immunotherapy in patients with advanced melanoma. Patients who responded well to treatment were more likely to have a specific type of gut bacteria called Faecalibacterium.
-
NewsTrial tests virus-immunotherapy combination for neuroendocrine tumors
A phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment. The ongoing study has completed its first three dose levels with no severe treatment-related side effects reported to date.
-
NewsMicrobiome insights may help predict immunotherapy benefit in kidney cancer
City of Hope researchers report that gut microbiome composition may influence how patients respond to immunotherapy combinations in metastatic renal cell carcinoma, pointing to a potential biomarker that could help guide treatment selection in the future. The microbiome is a rising focus at City of Hope, highlighted ...
-
NewsChemists use sea sponge bacteria to create new molecules for drug discovery
Chemists have synthesized new molecules derived from bacteria found in a Pacific Ocean sea sponge. They are the first to successfully synthesize two new marine natural products: tetradehydrohalicyclamine B and epi-tetradehydrohalicyclamine B.
-
NewsHPV self-collection boosts cervical cancer screening rates
The first major U.S. rollout of HPV self-collection shows benefits for patients and providers, including fewer pelvic exams and better follow-up for HPV-positive results.
-
NewsLargest-ever Canadian clinical trial tests ‘poop pills’ to improve immunotherapy for lung cancer
For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. A clinical trial will pair immunotherapy with fecal microbiota transplantation (FMT) with the goal of safely increasing treatment effectiveness. If successful, it could provide new treatment options for people with lung cancer.
-
Careers The First Microbiome Symposium of Puerto Rico and the Caribbean – new success for the COBRE Center for Microbiome Sciences
The inaugural Microbiome Symposium of Puerto Rico and the Caribbean marked a major milestone for microbiome science in the region and reinforced Puerto Rico’s growing leadership in interdisciplinary biomedical research, says chair Filipa Godoy-Vitorino of the University of Puerto Rico.
-
NewsStudy is first to detect and track multiple cancer-causing viruses in wastewater
A study is the first comprehensive approach to detect all known cancer-causing or oncogenic viruses concurrently by analyzing viral genomes in wastewater. The work shows that it is feasible to monitor the presence and levels of cancer-causing viruses, enabling the possibility of public health interventions in the future.
-
NewsBacteria may hold a cancer treatment clue
A review argues that tumors with reproducibly poor prognosis outcomes may share an overlooked feature: bacterial infection within the tumor microenvironment. These bacteria may weaken treatment by altering local immunity, damaging tissue structure, and even inactivating chemotherapeutic drugs.